What is MOMMY?
Established in September 2019, MOMMY is a longitudinal study that prospectively follows a birth cohort from the general population in Hong Kong and mainland China.
20,000
Families
Aim to recruit 20,000 pregnant mothers, their partners and children
>120,000 Samples
Collected from mothers, their partners and children
> 7
Years
Intensive follow-up until the child reaches teenage
WHY MOMMY MATTERS?
Exposure & Profile
Clinical Outcomes
Inception Cohort
Sub-studies
As a prospective longitudinal cohort, MOMMY tracks changes in the gut microbiome over time and their relationship to early life health outcomes.
With a diverse cohort, MOMMY identifies environmental, dietary, microbial, psychosocial, and genetic factors that influence the onset of common childhood diseases.
Understanding these factors will deepen our knowledge of disease pathogenesis and lead to new strategies for predicting, detecting, preventing, delaying, or reversing conditions.
EXPOSURE
& PROFILE.
Biosamples—including stool, breastmilk, vaginal swabs, skin swabs, and cord blood—have been prospectively collected from over 1,200 families (mothers, fathers, and offspring), beginning in pregnancy. We have now commenced metagenomic sequencing, enabling high-resolution characterization of microbial communities across key stages of early development.
Our strength lies in comprehensive clinical phenotyping, combining:
-
Follow-up by obstetricians and pediatricians
-
Neurodevelopmental and behavioral assessments
-
Environmental and dietary exposure profiling
